N. Mulla

Harnessing T-cell activity against prostate cancer: A therapeutic microparticulate oral cancer vaccine.

A. Parenky, Archana Akalkotkar, N. Mulla, 2019, Vaccine.

Novel sustained release formulation of levodopa-dendrimer conjugate

N. Mulla, 2011 .

Nanoparticle formulations that allow for sustained delivery and brain targeting of the neuropeptide oxytocin

N. Mulla, M. D'souza, Keegan Braz Gomes, 2018, International journal of pharmaceutics.

Trends in Nonparenteral Delivery of Biologics, Vaccines and Cancer Therapies

Rikhav P. Gala, Ruhi V. Ubale, T. Vo, 2015, Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies.

Mucosal Delivery of Particulate Breast Cancer Vaccine

P. Selvaraj, N. Mulla, M. D'souza, 2015 .

Nintedanib-cyclodextrin complex to improve bio-activity and intestinal permeability.

B. Vaidya, Snehal K. Shukla, Vivek Gupta, 2019, Carbohydrate polymers.

Role of In Vitro Release Methods in Liposomal Formulation Development: Challenges and Regulatory Perspective

Snehal K. Shukla, Vivek Gupta, N. Mulla, 2017, The AAPS Journal.

Boosting In-Vivo Anti-Tumor Immunity with an Oral Microparticulate Breast Cancer Vaccine and Low-Dose Cyclophosphamide

A. Parenky, N. Mulla, M. D'souza, 2023, Vaccines.

Role of In Vitro Release Methods in Liposomal Formulation Development: Challenges and Regulatory Perspective

Snehal K. Shukla, Vivek Gupta, N. Mulla, 2017, The AAPS Journal.